Belimumab in Remission of VASculitis
Clinical trial NCT01663623 · COMPLETED
Trial details
- NCT number
- NCT01663623
- Sponsor
- Human Genome Sciences Inc., a GSK Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-20
- Primary completion
- 2017-02-06
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.